VEON to Release 1Q26 Earnings Update on May 13, 2026

VEON to Release 1Q26 Earnings Update on May 13, 2026

Dubai and New York, April 17, 2026 – VEON Ltd. (Nasdaq: VEON), a global digital operator (together with its subsidiaries “VEON Group” or “the Group”), today confirms that it will release its financial and operating results for the first quarter ended March 31, 2026, at 8:00 GST (0:00 EST) on May 13, 2026.

VEON Group will also host a results conference call with senior management at 16:00 GST (8:00 EST) on the same day.


1Q26 results conference call

To register and access the event, please click here or copy and paste this link to the address bar of your browser: https://veon-1q-2026-results-presentation.open-exchange.net/

Once registered, a registration confirmation will be sent to the email address provided during registration with a link to access the webcast and dial-in details to listen to the conference call over the phone.


Join the Conversation Live

In addition to the webcast, the conference call will also be livestreamed on YouTube. This option allows you to follow the discussion in real time from any device without the need for registration or dial-in details. Simply click here or copy and paste this link to the address bar of your browser: https://www.youtube.com/live/VajlevOhsv4


Q&A

If you want to participate in the Q&A session, we ask that you select the ‘Yes’ option on the ‘Will you be asking questions live on the call?’ dropdown. That will bring you to a page where you can join the Q&A room by clicking ‘Connect to meeting’.

You will be brought into a zoom webinar where you can listen to the presentation and once Q&A begins, if you have a question, please use the ‘raise hand button’ on the bottom of your zoom screen. When it is your turn to speak, the moderator will announce your name as well as sending a message to your screen asking you to confirm you want to talk. Once accepted, please unmute your mic and ask your question.

To enhance engagement with the company’s shareholders and facilitate connections with its investors, VEON is partnering with Say Technologies to allow retail and institutional shareholders to submit and upvote questions, a selection of which will be answered by VEON management during the results conference call.

Starting on May 6, 2026, at 8:00 EST, the Q&A platform will become available, and all shareholders will be able to submit and upvote questions for VEON management by visiting: https://app.saytechnologies.com/veon-2026-q1.This Q&A platform will remain open until 24 hours before the conference call. Shareholders can email [email protected] for any support inquiries.

You can also submit your questions prior to the event to VEON Investor Relations at [email protected].

We look forward to your participation.

About VEON

VEON is a digital operator that provides connectivity and digital services over 150 million connectivity and more than 205 million digital users. Operating across five countries that are home to more than 6% of the world’s population, VEON is transforming lives through technology-driven services that empower individuals and drive economic growth. VEON is listed on NASDAQ. For more information, visit: https://www.veon.com.

Disclaimer

This press release contains “forward-looking statements”, as the phrase is defined in Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Forward-looking statements are not historical facts, and include statements relating to, among other things, expectations regarding management plans and the ability to successfully execute VEON’s operating model as well as its governance, strategic and development plans. Forward-looking statements are inherently subject to risks and uncertainties, many of which VEON cannot predict with accuracy and some of which VEON might not even anticipate. The forward-looking statements contained in this release speak only as of the date of this release. VEON does not undertake to publicly update, except as required by U.S. federal securities laws, any forward-looking statement to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.

Contact information

VEON
Investor Relations
[email protected]



European Firms Deploy GenAI in Mainframe Modernization

European Firms Deploy GenAI in Mainframe Modernization

Enterprises adopt AI-enhanced methods that align innovation and compliance, ISG Provider Lens® report says

LONDON–(BUSINESS WIRE)–
European companies adapting mainframe systems are moving from experimental to operational use of generative AI (GenAI) within standardized workflows, integrating it in key stages of modernization, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm.

The 2026 ISG Provider Lens® Mainframes — Services and Solutions report for Europe finds that enterprises are deploying AI-driven workflows built on deterministic engines to coordinate multiple tasks, including analysis, rule explanation, test creation and scaffolding. GenAI enhances existing modernization tools by speeding up analysis and planning while maintaining accuracy through verification.

“Enterprises increasingly expect explainable, production-grade and well-controlled AI within mainframe modernization processes,” said Matthias Paletta, director and ISG technology modernization solution lead for EMEA. “Providers that demonstrate repeatable, auditable GenAI capabilities are gaining credibility as organizations prioritize AI governance and integration.”

Mainframe modernization in Europe has entered a phase in which data sovereignty and regulatory demands are directly shaping how organizations carry out modernization. Enterprises demand clear, evidence-based assurances on where data is stored, how workloads are run and who can access and control encryption keys. They increasingly expect AI platforms and tools to operate in secure, isolated environments.

European organizations are moving away from large, one-time mainframe replacements toward gradual, carefully managed modernization programs to reduce risk, maintain compliance and accommodate limited skills and capacity. Providers are adopting a two-track approach that separates deterministic modernization, such as optimization and refactoring, from targeted transformation initiatives. This enables enterprises to modernize their mainframe environments incrementally while keeping core systems stable and avoiding disruptions caused by the scarcity of specialist skills.

While increasingly using GenAI in mainframe modernization, European enterprises are still taking a cautious approach, especially in critical systems. Rather than relying on fully automated AI-led changes, they are incorporating human review at key stages, along with clear records of decisions and thorough testing. This approach helps reduce risks and maintain accuracy. As a result, GenAI is increasingly used to support engineers and speed up work, while final decisions and accountability remain firmly with human teams.

“European enterprises are reshaping mainframe modernization around governance, stability and accountability,” said Oliver Nickels, lead author of the report. “Success depends on disciplined, risk-managed execution and transparent operations rather than rapid, large-scale change.”

The report also explores other mainframe technology trends affecting European enterprises, including reliance on hyperscalers to adapt to regional regulations and enterprises’ growing need for end-to-end alignment across consulting, modernization and managed operations.

For more insights into the mainframe-related challenges that enterprises face in Europe, and ISG’s advice for addressing them, see the ISG Provider Lens Focal Points briefing here.

The report evaluates the capabilities of 30 providers across three quadrants: Mainframe Technology Consulting, Mainframe as a Service and Application Modernization Services.

It names Atos, DXC Technology, HCLTech, Kyndryl, TCS and Wipro as Leaders in three quadrants each. Capgemini and Infosys are named as Leaders in two quadrants each. Accenture, Cognizant, LTM and Tech Mahindra are named as Leaders in one quadrant each.

In addition, Tech Mahindra is recognized as a Rising Star — a company with a “promising portfolio” and “high future potential” by ISG’s definition — in two quadrants. Additionally, Fujitsu is recognized as a Rising Star in one quadrant.

In the area of customer experience, mLogica is named the global ISG CX Star Performer for 2026 among mainframe service and solution providers. The provider earned the highest customer satisfaction scores in ISG’s Voice of the Customer survey, part of the ISG Star of Excellence™ program, the premier quality recognition for the technology and business services industry.

A customized version of the report is available from DXC Technology.

The 2026 ISG Provider Lens Mainframes — Services and Solutions report for Europe is available to subscribers or for one-time purchase on this webpage.

About ISG

ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world’s top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data and research, in-depth knowledge and governance of provider ecosystems, and the expertise of its 1,500 professionals worldwide working together to help clients maximize the value of their technology investments.

Press Contacts:

Laura Hupprich, ISG

+1 203-517-3100

[email protected]

Philipp Jaensch, ISG

+49 151 730 365 76

[email protected]

KEYWORDS: France Ireland United Kingdom Europe Germany

INDUSTRY KEYWORDS: Professional Services Security Data Analytics Technology Software Consulting Artificial Intelligence

MEDIA:

Logo
Logo

Adtran wins two FTTH Innovation Awards for AI‑driven network operations and home Wi‑Fi

Adtran wins two FTTH Innovation Awards for AI‑driven network operations and home Wi‑Fi

News summary:

  • Mosaic One Clarity recognized for applying explainable AI to shift fiber operations from reactive troubleshooting to proactive assurance

  • Adtran’s SDG 8000 and 9000 Series honored for delivering multigigabit, whole‑property Wi‑Fi with unified software and cloud management

  • Awards highlight Adtran’s focus on innovation that helps service providers scale fiber efficiently while improving customer experience

LONDON–(BUSINESS WIRE)–
Adtran today announced two wins at the FTTH Innovation Awards 2026, recognizing its leadership across in-home connectivity and AI‑driven network operations. The company received awards in the categories for ‘Active infrastructure – home network’ and ‘Artificial intelligence (AI), machine learning and other software.’ Organized by FTTH Council Europe, the annual awards honor technologies that advance fiber deployment while improving scalability, operational efficiency and user experience. Voted by FTTH Conference 2026 speakers, the results reflect peer recognition for Mosaic One Clarity and Adtran’s SDG 8000 and 9000 Series mesh Wi‑Fi solutions, both designed to address real deployment, performance and operational challenges facing service providers as fiber footprints expand.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414145132/en/

Adtran’s networking technology recognized with two FTTH Innovation Awards.

Adtran’s networking technology recognized with two FTTH Innovation Awards.

“These awards highlight where real value is being created in fiber today,” said Christoph Glingener, CTO of Adtran. “With Mosaic One Clarity, we’re applying explainable intelligence to help operators turn growing volumes of network data into action. As fiber networks scale and become more distributed, visibility alone isn’t enough. Teams need to know what matters most, understand root causes and take the right next step quickly. By embedding guided decision support directly into everyday operational workflows, Mosaic One Clarity helps expertise scale with the network itself. That ability to prioritize, act earlier and operate with confidence is becoming essential as service providers grow and evolve their networks.”

The winning technologies reflect a design philosophy focused on consistency and control across increasingly complex fiber environments. Mosaic One Clarity unifies network and subscriber data to help operations teams identify likely root causes, prioritize the issues that matter most and take guided action across multi‑vendor access and in‑home networks. Adtran’s SDG 8000 and 9000 Series complement this operational intelligence. Built on a common SmartOS foundation and managed through Intellifi®, they give service providers a unified platform for delivering multigigabit Wi‑Fi across single‑family homes, MDUs and shared indoor and outdoor spaces. Together, these capabilities help operators maintain predictable performance, simplify operations and evolve services without adding unnecessary complexity.

“It’s great to see how strongly our approach is resonating across the FTTH community,” commented Robert Conger, GM of strategy and solutions at Adtran. “Expectations for Wi‑Fi have fundamentally changed. Simply offering a fast connection is no longer the benchmark. Service providers must now ensure consistent, seamless performance across the entire property, whether that’s a home, an apartment building or a shared outdoor space. Our SDG 8000 and 9000 Series Wi-Fi gateways were designed for those real‑world deployment scenarios, combining multigigabit throughput with a common software foundation and cloud visibility. This gives providers a repeatable way to deliver great experiences, reduce operational friction and confidently extend fiber services wherever customers need them.”

About Adtran

ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the majority shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.

Published by

ADTRAN Holdings, Inc.

www.adtran.com

For media

Gareth Spence

+44 1904 699 358

[email protected]

For investors

Rob Fink

+1 646 809 4048

[email protected]

KEYWORDS: United Kingdom Europe

INDUSTRY KEYWORDS: Technology Mobile/Wireless Carriers and Services Software Networks Internet Hardware Data Management Artificial Intelligence

MEDIA:

Photo
Photo
Adtran’s networking technology recognized with two FTTH Innovation Awards.
Logo
Logo

Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock

NEW HAVEN, Conn., April 16, 2026 (GLOBE NEWSWIRE) — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC), today announced the pricing of its previously announced underwritten public offering of 11,600,000 shares of its common stock at a public offering price of $13.00 per share, for total proceeds of approximately $150 million, before deducting underwriting discounts and commissions and expenses payable by Trevi. All of the shares in the offering are being sold by Trevi. In addition, Trevi has granted the underwriters a 30-day option to purchase up to 1,740,000 additional shares of its common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about April 20, 2026, subject to satisfaction of customary closing conditions.

Morgan Stanley, Leerink Partners, Cantor, and Stifel are acting as joint book-running managers for the offering and Oppenheimer & Co. is acting as lead manager.

The shares are being offered by Trevi pursuant to a shelf registration statement on Form S-3 (File No. 333-291517), which was filed with the Securities and Exchange Commission (SEC) on November 13, 2025 and became effective automatically upon filing. This offering is being made only by means of a prospectus supplement and the accompanying prospectus that form a part of the registration statement. A preliminary prospectus supplement relating to and describing the terms of the offering has been filed with the SEC and is available on the SEC’s website located at www.sec.gov. The final terms of the offering will be disclosed in a final prospectus supplement to be filed with the SEC. When available, copies of the preliminary prospectus supplement, final prospectus supplement and the accompanying prospectus may also be obtained from Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, or by email at [email protected]; Leerink Partners LLC, Attention: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, or by telephone at (800) 808-7525, ext. 6105, or by email at [email protected]; Cantor Fitzgerald & Co., Attention: Capital Markets, 110 East 59th Street, New York 10022, or by email at [email protected]; or Stifel, Nicolaus & Company, Incorporated, Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, CA 94104, by telephone at (415) 364-2720 or by email at [email protected].

This press release shall not constitute an offer to sell, or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Trevi Therapeutics, Inc.

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine extended-release) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC). Haduvio is the first and only investigational therapy to show a statistically significant reduction in cough frequency in clinical trials across both patients with IPF chronic cough and in patients with RCC. Haduvio acts on the cough reflex arc both centrally and peripherally as a kappa agonist and a mu antagonist (KAMA), targeting opioid receptors that play a key role in controlling chronic cough. Nalbuphine is not currently scheduled by the U.S. Drug Enforcement Agency. Trevi intends to propose Haduvio as the trade name for oral nalbuphine ER. Its safety and efficacy have not been evaluated by any regulatory authority.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties and actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements about the anticipated closing of the public offering and the expected gross proceeds of the offering, among other things, and other statements containing the words “believes,” “anticipates,” “plans,” “expects,” “may,” and similar expressions. Risks that contribute to the uncertain nature of the forward-looking statements include: uncertainties related to market conditions and whether the conditions for the closing of the public offering will be satisfied, as well as other risks and uncertainties, set forth in the “Risk Factors” section of the preliminary prospectus supplement filed with the SEC on April 16, 2026, in Trevi’s Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC, and in any subsequent filings with the SEC. All forward-looking statements contained in this press release speak only as of the date on which they were made. Trevi undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made except as required by law.

Investor Contact

Jonathan Carlson
Trevi Therapeutics, Inc.
(203) 654 3286
[email protected]

Media Contact

Rosalia Scampoli
914-815-1465 
[email protected]



California State Treasurer Fiona Ma Visits Faraday Future’s Headquarters and Unveils EAI Robotics Education & Innovation Lab; FF EAI Ecosystem Strategy to Form a Closed Loop, Supporting California’s Ambition to Be the World’s Third-Largest Economy

California State Treasurer Fiona Ma Visits Faraday Future’s Headquarters and Unveils EAI Robotics Education & Innovation Lab; FF EAI Ecosystem Strategy to Form a Closed Loop, Supporting California’s Ambition to Be the World’s Third-Largest Economy

  • Treasurer Fiona Ma and other guests unveiled the FF EAI (Embodied AI) Robotics Education & Innovation Lab, a significant milestone in FF’s effort to build the first large-scale EAI education ecosystem in the United States.

  • As the first U.S. company to deliver both humanoid and bionic robots and to expand into the education market, FF’s first-mover advantage is accelerating into a self-reinforcing “Device-Data-Brain” flywheel effect, poised to make lasting contributions to California’s economy and EAI ecosystem.

  • Other distinguished guests included El Segundo Mayor Chris Pimentel, Former California State Senator Steven Bradford, and Ian Calderon, Former Majority Leader of the California State Assembly and CEO of Majority Advisors.

  • Treasurer Ma expressed active support across multiple areas, including FF products entering California’s GSA procurement catalog, K-12 and higher education EAI upgrades, EAI supply chain resource integration, and new factory site selection support.

  • FF’s “Three-in-One” EAI ecosystem strategy has achieved its initial closed loop, demonstrated through live robot capabilities including K-12 education programming, dance and martial arts performances, hand-eye-brain coordinated object grasping, LiDAR-enabled timed and location-based inspection, VR teleoperation data collection, and security patrol.

  • Treasurer Ma also experienced the FF 91 2.0 Futurist Alliance and FX Super One firsthand, gaining direct insight into FF’s product strength and technical capabilities in EAI EVs.

  • Mayor Pimentel attended alongside Treasurer Ma, jointly supporting FF’s California EAI education pilot center and a new EAI industry landmark in Silicon Beach; Lynwood Unified School District Representative David Ramirez also attended and confirmed the district’s intent to collaborate with FF on EAI education.

LOS ANGELES–(BUSINESS WIRE)–
Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future,” “FF,” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, today announced that California State Treasurer Fiona Ma visited FF’s El Segundo headquarters on April 16, experiencing FF’s EAI robotics and EAI EVs firsthand and attending the unveiling of the FF EAI Robotics Education & Innovation Lab. El Segundo Mayor Chris Pimentel, Former California State Senator Steven Bradford, and Ian Calderon, Former Majority Leader of the California State Assembly and CEO of Majority Advisors, also attended. This marks the first visit to FF by a California state-level government official and a significant moment for the Company’s EAI ecosystem strategy.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260416133067/en/

California State Treasurer Fiona Ma and El Segundo Mayor Chris Pimentel Visit Faraday Future’s U.S. Headquarters and Help Company Unveil Its EAI Robotics Education & Innovation Lab

California State Treasurer Fiona Ma and El Segundo Mayor Chris Pimentel Visit Faraday Future’s U.S. Headquarters and Help Company Unveil Its EAI Robotics Education & Innovation Lab

At the ceremony, the Company officially announced the establishment of the FF EAI Robotics Education & Innovation Lab, with Treasurer Ma personally unveiling the lab’s plaque, representing a concrete step toward FF’s goal of becoming a pilot center in California for EAI education. Lynwood Unified School District Representative David Ramirez attended and confirmed the district’s intent to collaborate with FF on EAI education. Treasurer Ma also participated in the unveiling of FF’s California Women in EAI & STEM Innovation Center, underscoring FF’s long-term commitment to advancing women’s participation in EAI and STEM innovation.

“This was my first time here visiting FF, I was very impressed with everyone I met and everything I saw, from the robots to their cars. The technology is here, it is going to make our lives easier and more efficient,” said Treasurer Ma. “I want to thank FF for locating your HQ here in El Segundo, and for building your cars in Hanford, CA, and creating both engineering and manufacturing jobs. With your help, I hope California will soon become the 3rd largest global economy in the world.”

During the visit, Treasurer Ma and Mayor Pimentel engaged in in-depth discussions with the Company across several key areas, including listing FF’s EAI robotics products in California and city government GSA (General Service Administration) procurement catalogs, and expanding access to public procurement channels such as schools and educational institutions. The conversations also covered AI and EAI upgrades across K-12 and higher education systems, robotics data collection partnerships, EAI supply chain integration, and site selection support for new factory sites to scale EAI terminal production capacity and data collection and training infrastructure. Following the discussions, Treasurer Ma expressed active support across all the above areas.

FF also presented the progress of its “Three-in-One” EAI ecosystem strategy. As the first U.S. company to deliver both humanoid and bionic robots, FF has achieved real-world deployment across multiple core application scenarios. The on-site demonstration covered key use cases including education, performance, tour guide, home security, and data collection, with live robot capabilities including K-12 education programming, dance and martial arts performances, vision-guided object grasping, LiDAR-enabled timed and location-based inspection, VR teleoperation data collection, and security patrol. FF representatives also briefed guests on the Company’s centralized and decentralized Physical AI data factory development plans, noting that an initial data collection and training model is already in place and that a Physical AI data factory is actively in preparation. The “Device-Data-Brain” closed loop has taken shape, and the flywheel effect is beginning to emerge.

Treasurer Ma and Mayor Pimentel also experienced the FF 91 2.0 Futurist Alliance and FX Super One firsthand, gaining direct insight into FF’s product strength and technical capabilities in the EAI EV space. FF remains committed to advancing the phased delivery of the FX Super One, supporting the reshoring of manufacturing to California, and building its EAI “Robot & Vehicle +” ecosystem.

“The visit by California State Treasurer Fiona Ma and El Segundo Mayor Chris Pimentel is a strong recognition of the work FF has been doing to build the EAI ecosystem right here in California,” said YT Jia, Founder and Co-CEO of FF. “FF is the first U.S. company to deliver both vehicles, along with humanoid and bionic robots to the marketplace, and we are putting that advantage to work — bringing high-quality tech jobs, industrial investment, and EAI education to this state. We are committed to making this a defining moment for the EAI industry.”

This joint visit by Treasure Ma, Mayor Pimentel, Senator Bradford, and Assembly Member Calderon marks a meaningful breakthrough for FF in terms of government acknowledgment. For the Company, alignment on policy support will accelerate execution across FF’s commercial roadmap, reinforcing its position as a core EAI enterprise in Silicon Beach. For the industry, FF’s “Three-in-One” EAI ecosystem sets a practical benchmark for real-world EAI commercialization. For the California economy, FF’s deepening local footprint, spanning factory site development, supply chain buildout, and data factory establishment, is expected to bring high-quality tech employment and substantial industrial investment, supporting California’s continued leadership as the world’s fourth-largest economy.

ABOUT FARADAY FUTURE

Faraday Future is a California-based global Embodied AI (EAI) ecosystem Company founded in 2014 and is dedicated to reshaping the future of mobility through vehicle electrification, intelligent technologies, and AI innovation. Its flagship vehicle, the FF 91, began deliveries in 2023 and reflects the brand’s pursuit of ultra-luxury, cutting-edge technology, and high performance. FF’s second brand, FX, targets the high-volume mainstream vehicle market. Its first model, Super One, is positioned as a first-class EAI-MPV, with deliveries planned to begin in 2026. FF recently announced its entry into the Embodied AI Robotics business with sales beginning this year, connecting its future strategy of bringing a new era of EAI vehicles and EAI robotics. For more information, please visit https://www.ff.com/.

FORWARD LOOKING STATEMENTS

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “plan to,” “can,” “will,” “should,” “future,” “potential,” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements, which include statements regarding FF’s entry into the embodied AI robotics market and future deliveries, involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control, which could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors that may affect actual results or outcomes include, among others: demand for our robotics products; competition in the robotics industry, which includes companies with far superior experience, funding and name recognition; our reliance on a single OEM for most of our robotics products; our ability to get the planned robotics products to comply with all applicable U.S. rules and regulations; the ability of the robotics OEM to timely supply robotics to the Company; the ability of the Company to adequately insure its robotics products; tariff uncertainty for imported products, particularly from China; the ability of the U.S. Department of Commerce to review, condition, or prohibit robotics-related transactions with a China OEM; demand from automobile dealers for robotics products; the Company’s ability to maintain its listing on Nasdaq; the Company’s ability to timely regain compliance with Nasdaq’s minimum bid requirement; the possibility of the Company’s common stock being suspended from trading on Nasdaq if its closing price is $0.10 or less for 10 consecutive trading days; the availability of sufficient share capital to execute on its strategy, which the Company currently lacks; the agreement of stockholders to substantially increase the Company’s share capital, which could result in substantial additional dilution; the Company’s ability to homologate FX vehicles for sale; the Company’s ability to secure the necessary funding to execute on the FX strategy, which will be substantial; the Company’s ability to secure an occupancy certificate for its Hanford facility; the Company’s ability to continue as a going concern and improve its liquidity and financial position; the Company’s ability to pay its outstanding obligations; the Company’s ability to remediate its material weaknesses in internal control over financial reporting and the risks related to the restatement of previously issued consolidated financial statements; the Company’s limited operating history and the significant barriers to growth it faces; the Company’s history of losses and expectation of continued losses; the success of the Company’s payroll expense reduction plan; the Company’s ability to execute on its plans to develop and market its vehicles and robots and the timing of these development programs; the Company’s estimates of the size of the markets for its vehicles and robots and cost to bring those vehicles to market; the rate and degree of market acceptance of the Company’s vehicles; the Company’s ability to cover future warranty claims; the success of other competing manufacturers; the performance and security of the Company’s vehicles; current and potential litigation involving the Company; the Company’s ability to receive funds from, satisfy the conditions precedent of and close on the various financings described elsewhere by the Company; the result of future financing efforts, the failure of any of which could result in the Company seeking protection under the Bankruptcy Code; the Company’s indebtedness; the Company’s ability to use its “at-the-market” program; insurance coverage; general economic and market conditions impacting demand for the Company’s products; potential negative impacts of a reverse stock split; potential cost, headcount and salary reduction actions may not be sufficient or may not achieve their expected results; circumstances outside of the Company’s control, such as natural disasters, climate change, health epidemics and pandemics, terrorist attacks, and civil unrest; risks related to the Company’s operations in China; the success of the Company’s remedial measures taken in response to the Special Committee findings; the Company’s dependence on its suppliers and contract manufacturer; the Company’s ability to develop and protect its technologies; the Company’s ability to protect against cybersecurity risks; and the ability of the Company to attract and retain employees, any adverse developments in existing legal proceedings or the initiation of new legal proceedings, and volatility of the Company’s stock price. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the Company’s Form 10-K filed with the SEC on March 31, 2025; Form 10-Qs for the quarters ended June 30, 2025 and September 30, 2025 filed with the SEC on May 9, 2025, August 19, 2025 and November 21, 2025, respectively; the Company’s Form 10-K filed with the SEC on March 31, 2026; and other documents filed by the Company from time to time with the SEC.

Investors: [email protected]

Investors (Chinese): [email protected]

Media: [email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Technology EV/Electric Vehicles Automotive Automotive Manufacturing Manufacturing Hardware Robotics Primary/Secondary Education Artificial Intelligence

MEDIA:

Photo
Photo
California State Treasurer Fiona Ma and El Segundo Mayor Chris Pimentel Visit Faraday Future’s U.S. Headquarters and Help Company Unveil Its EAI Robotics Education & Innovation Lab
Photo
Photo
California State Treasurer Fiona Ma and El Segundo Mayor Chris Pimental Visit Faraday Future’s U.S. Headquarters and Help Company Unveil Its EAI Robotics Education & Innovation Lab
Photo
Photo
California State Treasurer Fiona Ma and El Segundo Mayor Chris Pimentel Visit Faraday Future’s U.S. Headquarters and Help Company Unveil Its EAI Robotics Education & Innovation Lab
Photo
Photo
California State Treasurer Fiona Ma and El Segundo Mayor Chris Pimentel Visit Faraday Future’s U.S. Headquarters and Help Company Unveil Its EAI Robotics Education & Innovation Lab
Logo
Logo

JetBlue Expands Transatlantic Service from Boston with New Flights to Barcelona Starting Today

JetBlue Expands Transatlantic Service from Boston with New Flights to Barcelona Starting Today

New summer seasonal service strengthens JetBlue’s transatlantic network from Boston and connects New England with Barcelona

To celebrate the launch, limited one-way fares are available starting at $349 and €399 in Core and €1,699 and $1,799 in Mint for Boston–Barcelona route

BOSTON–(BUSINESS WIRE)–
JetBlue (Nasdaq: JBLU), New England’s leading leisure airline, today launched new summer seasonal service between Boston Logan International Airport (BOS) and Josep Tarradellas Barcelona–El Prat Airport (BCN). The route expands JetBlue’s transatlantic flying and further positions Boston as an important European gateway and focus city, while showcasing the cultural and gastronomic richness of Barcelona, a region with its own distinct identity.

Known for its award-winning Mint® experience and elevated onboard service, JetBlue continues to redefine accessible premium travel across the Atlantic. The Boston–Barcelona route supports growing demand for leisure, business, and academic travel, strengthens ties between New England and Spain’s Catalonia region, and complements JetBlue’s broader European network. The airline will also launch seasonal service between Boston and Milan on May 11. Through Boston, customers can connect to JetBlue’s extensive network across the U.S., Latin America, and the Caribbean.

“The launch of service between Boston and Barcelona marks another exciting step in JetBlue’s transatlantic service,” said Marty St. George, president, JetBlue. “We’re excited to introduce our first service to Spain’s Catalonia region, connecting two dynamic global hubs and expanding our international reach. This route builds on our existing transatlantic presence from Boston and gives customers more choice and value when traveling between the U.S. and Europe.”

“From the Barcelona Air Route Development Committee (BARDC), formed by Aena, the Government of Catalonia, Barcelona City Council, and the Barcelona Chamber of Commerce, we have supported the launch of the Boston–Barcelona route. JetBlue’s arrival in the city marks an important milestone, connecting two global hubs and enhancing international connectivity,” said Vanessa Requena, Head of Management Office of JT Barcelona-El Prat Airport. “This new route strengthens economic, academic, and cultural ties between the two cities and responds to strong demand, with more than 1.5 million indirect passengers traveling between the U.S. and Barcelona, including over 59,000 between Boston and Barcelona in 2025.”

Connecting Communities Across the Atlantic: Boston and Barcelona

Barcelona becomes JetBlue’s second destination in Spain, following the launch of service to Madrid last year, and marks the airline’s seventh city served in Europe. Renowned for its art, iconic architecture, and coastal appeal, Barcelona will come alive this summer with a vibrant lineup of cultural events, concerts, and major sporting moments—further cementing its status as one of Europe’s premier destinations.

This new service strengthens access between Boston and Barcelona, building on long-standing cultural, academic, and business ties. Both cities are global hubs for innovation, life sciences, higher education, and the arts, and the route supports deeper collaboration between these two dynamic regions.

With the addition of Barcelona and upcoming service to Milan, JetBlue will operate up to nine daily nonstop flights between Boston and Europe this summer, highlighting its continued investment in building the East Coast’s leading leisure network as part of its JetForward strategy. From Boston, the airline offers more than 130 daily departures to over 65 destinations.

Daily seasonal service between Boston (BOS) and Barcelona (BCN)

(Through October 25, 2026)

All times local

BOS-BCN Flight #345

BCN-BOS Flight #346

8:04 p.m. – 09:45 a.m.

12:50 p.m. – 3:38 p.m.

Book Better

To celebrate the launch, limited one-way introductory fares are available starting at $349 in Core and $1,799 in Mint for Boston-originating travelers, and from €399 in Core and €1,699 in Mint for Barcelona-originating travelers. Fares are available for a limited time on jetblue.com.1

The JetBlue Experience

Flights to Barcelona will operate on JetBlue’s A321 aircraft with Mint, featuring fully lie-flat private suites and artisan dining curated by acclaimed NYC local restaurants. Combined with JetBlue’s signature Core experience, which includes free Fly-Fi, seatback entertainment, and complimentary snacks and drinks, the airline offers all customers an elevated experience at a competitive price.

JetBlue’s award-winning core experience also raises the bar for travelers who typically fly “coach,” but still want a great experience at an attractive fare with complimentary meals from culinary partner Dig Inn, a wide selection of brand-name snacks and beverages, including beer, wine, and liquor, and seatback screens at every seat.2 Customers in both Mint and Core stay connected with fast, free, and unlimited Fly-Fi, and enjoy a multi-screen experience onboard—just like they do at home. Together, JetBlue’s transatlantic service is redefining affordable premium travel while contributing positively to the destinations it serves.

For more details on JetBlue’s transatlantic service, visit: https://www.jetblue.com/flying-with-us/uk-and-europe.

Boston’s Transatlantic 2026 Service:

Destination

Frequency

Starting Date

Amsterdam (AMS)

1x daily

Year-round service

Barcelona (BCN)*

1x daily

Launches April 16, 2026, seasonal

Dublin (DUB)

1x daily

Resumes April 16, 2026, seasonal

Edinburgh (EDI)

1x daily

Resumes April 16, 2026, seasonal

London-Gatwick (LGW)

1x daily

Resumes May 21, 2026, seasonal

London-Heathrow (LHR)

1x daily

Year-round service

Madrid (MAD)

1x daily

Resumes April 16, 2026, seasonal

Milan (MXP)*

1x daily

Launches May 11, 2026, seasonal

Paris (CDG)

1x daily

Year-round service

*New JetBlue destination for 2026 summer travel season.

New York-JFK Transatlantic 2026 Service:

Destination

Frequency

Starting Date

Dublin (DUB)

1x daily

Resumes April 29, 2026, seasonal

Edinburgh (EDI)

1x daily

Resumes April 29, 2026, seasonal

London-Heathrow (LHR)

2x daily

Year-round service

Paris (CDG)

1x daily

Year-round service

About JetBlue

JetBlue is New York’s Hometown Airline® and a leading carrier in Boston, Fort Lauderdale-Hollywood, Los Angeles, Orlando, and San Juan. JetBlue carries customers to more than 100 destinations throughout the United States, Latin America, the Caribbean, Canada, and Europe. For more information and the best fares, visit jetblue.com.

  1. Boston (BOS) – Barcelona (BCN): One way only for U.S. point of sale only. Book by: 4/18/2026 for travel 5/31/2026 – 7/13/2026. Saturday, Sunday and Monday travel only.

    Barcelona (BCN) – Boston (BOS): One way only for EU point of sale only. Book by: 4/18/2026 for travel 6/10/2026 – 7/15/2026. Tuesday and Wednesday travel only.

  2. Fly-Fi® and live television are available on all JetBlue-operated flights. Availability and coverage area may vary by aircraft. Details on inflight wi-fi and entertainment: https://www.jetblue.com/flying-with-us.

 

JetBlue Corporate Communications Team

Tel: +1.718.709.3089

[email protected]

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Transportation Air Transport Travel

MEDIA:

OraSure Technologies Appoints John D. Bertrand to its Board of Directors

Enters into Cooperation Agreement with Altai Capital

Board to Seek Shareholder Approval for Declassification at the 2026 Annual Meeting

BETHLEHEM, Pa., April 16, 2026 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (“OraSure” and “OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the appointment of John D. Bertrand to its Board of Directors as an independent director, effective immediately.

Mr. Bertrand is a healthcare technology executive with more than a decade of experience driving AI-enabled innovation in diagnostics. He co-founded Digital Diagnostics Inc. and most recently served as its Chief Executive Officer, helping to transform the company from a research-stage organization into a global commercial platform for disease diagnosis. Previously, Mr. Bertrand held senior leadership positions at Epic Systems Corporation, with responsibility spanning product development, customer success, and business development. He also served as a Senior Advisor to Bain Capital and as Executive in Residence at 8VC, with a focus on AI applications in healthcare information technology.

OraSure also announced that it will seek shareholder approval at its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) to declassify the Board. The declassification proposal will be detailed in the Company’s 2026 Proxy Statement, which will be filed with the U.S. Securities and Exchange Commission in advance of the Annual Meeting.

“We are pleased to welcome John to our Board as we continue to make meaningful progress in advancing our multi-year transformation strategy,” said Jack Kenny, Chair of the OTI Board. “OraSure is well positioned to continue accelerating our growth and driving margin improvement, and we believe John’s experience in AI-enabled diagnostics and commercial healthcare technology will strengthen our strategic efforts. Our proposal to declassify the Board further underscores our commitment to strong governance, disciplined oversight, and ongoing shareholder engagement as we work to deliver sustained, long-term value.”

In connection with the updates announced today and following constructive engagement, the Company has entered into a Cooperation Agreement with Altai Capital Management, L.P. (“Altai”). Under the terms of the Cooperation Agreement, Altai will withdraw its director nominations for the Annual Meeting and members of OraSure’s Board and management team will meet with Altai on a regular basis to discuss financial and strategic matters.

“We are pleased with the outcome of our engagement with OraSure and the steps the Company has taken to enhance its Board and governance practices,” said Rishi Bajaj, Founder and CIO of Altai. “John’s appointment, together with our ongoing constructive dialogue with OraSure’s Board and management team, strengthens our confidence that the Company is on the path to delivering sustained value. We believe OraSure is well positioned to create meaningful long-term value for shareholders as it executes its strategy.”

The Cooperation Agreement includes customary standstill, voting, and other provisions and will be filed on a Form 8-K with the U.S. Securities and Exchange Commission.

Evercore is serving as financial advisor, Goodwin Procter LLP is serving as legal advisor, and Joele Frank, Wilkinson Brimmer Katcher is serving as strategic communications advisor to OraSure.

McDermott Will & Schulte LLP is serving as legal advisor and ASC Advisors is serving as strategic communications advisor to Altai.

About OraSure Technologies, Inc.

OraSure Technologies, Inc. (“OraSure” and “OTI”) transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. Together with its wholly-owned subsidiaries, DNA Genotek Inc., Sherlock Biosciences, Inc., and BioMedomics, Inc., OTI is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physicians’ offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com

Forward-Looking Statements

This press release contains certain forward-looking statements. Forward-looking statements are not guarantees of future performance or results. Known and unknown factors could cause actual performance or results to be materially different from those expressed or implied in these statements. Factors that could affect our results are discussed more fully in our filings with the U.S. Securities and Exchange Commission (the “SEC”), including our registration statements, Annual Report on Form 10-K for the year ended December 31, 2025, and other filings with the SEC. Although forward-looking statements help to provide information about future prospects, readers should keep in mind that forward-looking statements may not be reliable. Readers are cautioned not to place undue reliance on the forward-looking statements. The forward-looking statements are made as of the date of this press release and OraSure undertakes no duty to update these statements.

Important Additional Information

OraSure intends to file a proxy statement and proxy card with the SEC in connection with its solicitation of proxies for the Company’s 2026 annual meeting of stockholders (the “Annual Meeting”). STOCKHOLDERS OF THE COMPANY ARE STRONGLY ENCOURAGED TO READ SUCH PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO), THE ACCOMPANYING PROXY CARD AND ALL OTHER DOCUMENTS FILED WITH, OR FURNISHED TO, THE SEC IN CONNECTION WITH THE ANNUAL MEETING CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING. Stockholders will be able to obtain the Company’s proxy statement, any amendments or supplements to the proxy statement and other documents filed by the Company with the SEC at no charge at the SEC’s website at www.sec.gov. Copies will also be available at no charge at the Company’s website at https://orasure.gcs-web.com/financial-information/sec-filings.

Participant Information

The Company, each of its directors (Carrie Eglinton Manner (Chief Executive Officer), Steven K. Boyd, Nancy J. Gagliano, M.D., M.B.A., John P. Kenny, Lelio Marmora and Robert W. McMahon) and one of its executive officers in addition to Ms. Eglinton Manner (Kenneth J. McGrath, Chief Financial Officer) are deemed to be “participants” (as defined in Schedule 14A under the Securities Exchange Act of 1934, as amended) in the solicitation of proxies from the Company’s stockholders in connection with matters to be considered at the Annual Meeting. Information about the names of the Company’s directors and officers, their respective interests in the Company by security holdings or otherwise, and their respective compensation is set forth in the sections entitled “Executive Officers,” “Election of Directors,” “Compensation Discussion and Analysis,” “Director Compensation,” and “Stock Ownership of Certain Beneficial Owners and Management” in the Company’s definitive proxy statement on Schedule 14A for the Company’s 2025 Annual Meeting of Stockholders, filed with the SEC on April 4, 2025 (available here). Supplemental information regarding the participants’ holdings of the Company’s securities can be found in SEC filings on Initial Statements of Beneficial Ownership of Securities on Form 3 or Statements of Change in Ownership on Form 4 filed with the SEC on March 27, 2025 for Mr. Kenny (available here and here), Mr. Marmora (available here), Mr. McMahon (available here), Ms. Gagliano (available here); on June 5, 2025 for Ms. Eglinton Manner (available here); June 25, 2025 for Mr. Kenny (available here); on August 4, 2025 for Mr. McMahon (available here); on August 11, 2025 for Mr. McGrath (available here); on September 26, 2025 for Mr. Kenny (available here and here); December 2, 2025 for Ms. Gagliano (available here) and Mr. Boyd (available here); on December 19, 2025 for Mr. Kenny (available here and here); on March 3, 2026 for Mr. McGrath (available here) and Ms. Eglinton Manner (available here); on March 16, 2026 for Mr. McGrath (available here) and Ms. Eglinton Manner (available here); on March 23, 2026 for Ms. Eglinton Manner (available here) and Mr. McGrath (available here); and on March 30, 2026 for Mr. Boyd (available here). Such filings are also available on the Company’s website at https://orasure.gcs-web.com/financial-information/sec-filings. Updated information regarding the identity of participants, and their direct or indirect interests, by security holdings or otherwise, will be set forth in the Company’s proxy statement on Schedule 14A and other materials to be filed with the SEC in connection with the Annual Meeting.

Investor Contact:

Jason Plagman
VP, Investor Relations
[email protected]
Media Contact:

Amy Koch
Director, Corporate Communications
[email protected]
   
  Adam Pollack / Chloe Karp
Joele Frank, Wilkinson Brimmer Katcher
(212) 355-4449





Marcus Corporation Announces First Quarter Fiscal 2026 Release Date and Conference Call

Marcus Corporation Announces First Quarter Fiscal 2026 Release Date and Conference Call

MILWAUKEE–(BUSINESS WIRE)–Marcus Corporation (NYSE: MCS) today announced it will report results for the first quarter of fiscal 2026 prior to the stock market open on Thursday, April 30, 2026. The release will be followed by a conference call at 10:00 a.m. Central/11:00 a.m. Eastern time.

Participants may listen to the call live on the internet through the investor relations section of the company’s website: investors.marcuscorp.com, or by dialing 1- 646-307-1963 and entering the passcode 8761289. Listeners should dial in to the call at least 5-10 minutes prior to the start of the call or should go to the website at least 15 minutes prior to the call to download and install any necessary audio software.

A telephone replay of the conference call will be available through Thursday, May 7, 2026, by dialing 1-800-770-2030 and entering passcode 8761289. The webcast will be archived on the company’s website until its next earnings release.

About Marcus Corporation

Headquartered in Milwaukee, Marcus Corporation is a leader in the entertainment and hospitality industries, with significant company-owned real estate assets. Marcus Corporation’s theatre division, Marcus Theatres®, is the fourth largest theatre circuit in the U.S. and currently owns or operates 985 screens at 78 locations in 17 states under the Marcus Theatres, Movie Tavern® by Marcus and BistroPlex® brands. The company’s hospitality division, Marcus® Hotels & Resorts, owns and/or manages 17 hotels, resorts and other properties in eight states. For more information, please visit the company’s website at www.marcuscorp.com.

For additional information, contact:

Chad Paris

(414) 905-1100

[email protected]

KEYWORDS: Wisconsin United States North America

INDUSTRY KEYWORDS: Entertainment Other Entertainment Film & Motion Pictures General Entertainment Theatre Lodging Travel

MEDIA:

Logo
Logo

Enveric Biosciences Announces Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Enveric Biosciences Announces Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$5 million upfront with up to approximately $8.9 million of potential aggregate proceeds upon the exercise in full of warrants

CAMBRIDGE, Mass.–(BUSINESS WIRE)–
Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that it has entered into definitive agreements for the purchase and sale of 2,222,223 shares of its common stock (or pre-funded warrants in lieu thereof), Series I warrants to purchase up to an aggregate of 2,222,223 shares of common stock and short-term Series J warrants to purchase up to an aggregate of 2,222,223 shares of common stock, at a purchase price of $2.25 per share (or pre-funded warrant in lieu thereof) and accompanying warrants in a private placement priced at-the-market under Nasdaq rules. The warrants will have an exercise price of $2.00 per share and will be exercisable immediately upon issuance. The Series I warrants will expire five years after the effective date of the Resale Registration Statement (as defined below) and the short-term Series J warrants will expire eighteen months after the effective date of the Resale Registration Statement.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

The aggregate gross proceeds to the Company from the offering are expected to be approximately $5 million before deducting placement agent fees and other offering expenses payable by the Company. The potential additional gross proceeds to the Company from the Series I warrants and the short-term Series J warrants, if fully exercised on a cash basis, will be approximately $8.9 million. No assurance can be given that any of the warrants will be exercised, or that the Company will receive cash proceeds from the exercise of the warrants. The closing of the offering is expected to occur on or about April 17, 2026, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering for product development, working capital and general corporate purposes.

The securities described above are being offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”) and/or Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants sold in the offering, have not been registered under the Securities Act or applicable state securities laws. Accordingly, such securities may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. Pursuant to a registration rights agreement, the Company has agreed to file one or more registration statements with the SEC covering the resale of the unregistered securities to be issued in the offering (the “Resale Registration Statement”).

This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

About Enveric Biosciences

Enveric Biosciences (NASDAQ: ENVB) is a biotechnology company focused on developing next-generation, small-molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders. By leveraging a differentiated drug discovery platform and a growing library of patent protected chemical structures, Enveric is advancing a pipeline of novel compounds designed to promote neuroplasticity without hallucinogenic effects. Enveric’s lead candidate, EB-003, is the first known compound designed to selectively engage both 5-HT2A and 5-HT1B receptors with the potential to deliver fast-acting, durable antidepressant and anxiolytic effects with outpatient convenience. For more information, please visit www.enveric.com.

Forward-Looking Statements

This press release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as “plans,” “expects” or “does not expect,” “proposes,” “budgets,” “explores,” “schedules,” “seeks,” “estimates,” “forecasts,” “intends,” “anticipates” or “does not anticipate,” or “believes,” or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, should, would, or might occur or be achieved. Forward-looking statements may include statements regarding beliefs, plans, expectations, or intentions regarding the future and are based on the beliefs of management as well as assumptions made by and information currently available to management, including, but not limited to, statements regarding the completion of the offering, including the expected closing date of the offering, the satisfaction of customary closing conditions related to the offering, the exercise of the warrants prior to their expiration and anticipated potential additional aggregate gross proceeds upon the exercise of warrants, and the anticipated use of proceeds from the offering. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, including, but not limited to, the ability of Enveric to: finalize and submit its IND filing to the U.S. Food and Drug Administration; carry out successful clinical programs; achieve the value creation contemplated by technical developments; avoid delays in planned clinical trials; establish that potential products are efficacious or safe in preclinical or clinical trials; establish or maintain collaborations for the development of therapeutic candidates; obtain appropriate or necessary governmental approvals to market potential products; obtain future funding for product development and working capital on commercially reasonable terms; obtain licenses and partnerships with pharmaceutical companies; scale-up manufacture of product candidates; respond to changes in the size and nature of competitors; hire and retain key executives and scientists; secure and enforce legal rights related to Enveric’s products, including patent protection; identify and pursue alternative routes to capture value from its research and development pipeline assets; continue as a going concern; and manage its future growth effectively.

A discussion of these and other factors, including risks and uncertainties with respect to Enveric, is set forth in Enveric’s filings with the Securities and Exchange Commission, including Enveric’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Enveric disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Investor Relations

Tiberend Strategic Advisors, Inc.

David Irish

(231) 632-0002

[email protected]

Media Relations

Tiberend Strategic Advisors, Inc.

Casey McDonald

(646) 577-8520

[email protected]

KEYWORDS: Massachusetts United States North America Canada

INDUSTRY KEYWORDS: Research Mental Health Neurology Other Health Biotechnology General Health Pharmaceutical Health Science Other Science

MEDIA:

Logo
Logo

Brookfield Corporation Announces Pricing of C$500 Million of Medium-Term Notes Due 2036 and C$250 Million Re-Opening of Medium-Term Notes Due 2055

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION TO THE UNITED STATES

BROOKFIELD, NEWS, April 16, 2026 (GLOBE NEWSWIRE) — Brookfield Corporation (NYSE: BN, TSX: BN) today announced the pricing of a public offering of C$500 million aggregate principal amount of medium-term notes due April 21, 2036 (the “2036 notes”), which will bear interest at a rate of 4.803% per annum, payable semi-annually, and the pricing of a C$250 million re-opening of its 5.399% medium term notes due December 11, 2055 (the “2055 notes” and together with the 2036 notes, the “notes”).

The 2055 notes will form part of the same series as the already outstanding C$650 million aggregate principal amount of 5.399% notes due December 11, 2055 (the “existing notes”), which were issued on December 11, 2025. After giving effect to the re-opening, the aggregate principal amount of the series will be C$900 million. The terms of the 2055 notes will be identical to the existing notes, other than the issue date and the issue price. The 2055 notes will be issued at a price equal to 99.495% of their face value plus accrued and unpaid interest from December 11, 2025 (the issue date of the existing notes) through, but excluding, the date of delivery of such notes, with an effective yield of 5.433%, if held to maturity.

The notes are expected to be assigned a credit rating of A- by Standard & Poor’s, A- by Fitch, A3 by Moody’s and A by DBRS.

Brookfield Corporation intends to use the net proceeds from the sale of the notes for general corporate purposes.

The notes are being offered through a syndicate of agents led by CIBC Capital Markets, BMO Capital Markets, National Bank Capital Markets, RBC Capital Markets, Scotiabank and TD Securities.

The notes are being offered under an existing base shelf prospectus filed in Canada. The offering is being made only by means of a prospectus supplement and pricing supplements relating to the offering of the notes. You may obtain these documents for free on SEDAR+ at www.sedarplus.ca. Before you invest, you should read these documents and other public filings by Brookfield Corporation for more complete information about Brookfield Corporation and this offering.

This news release shall not constitute an offer to sell or the solicitation of an offer to buy the securities in any jurisdiction, nor shall there be any offer or sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities being offered have not been approved or disapproved by any regulatory authority nor has any such authority passed upon the accuracy or adequacy of the short form base shelf prospectus, the prospectus supplement or the pricing supplements. The offer and sale of the securities has not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold in the United States or to United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws.

About Brookfield Corporation

Brookfield Corporation is a leading global investment firm focused on building long-term wealth for institutions and individuals around the world. We have three core businesses: Alternative Asset Management, Wealth Solutions, and our Operating Businesses which are in energy, infrastructure, private equity, and real estate.

We have a track record of delivering 15%+ annualized returns to shareholders for over 30 years, supported by our unrivaled investment and operational experience. Our conservatively managed balance sheet, extensive operational experience, and global sourcing networks allow us to consistently access unique opportunities. At the center of our success is the Brookfield Ecosystem, which is based on the fundamental principle that each group within Brookfield benefits from being part of the broader organization. Brookfield Corporation is publicly traded in New York and Toronto (NYSE: BN, TSX: BN).

For more information, please contact:

Media:
Kerrie McHugh
Tel: (212) 618-3469
Email: [email protected]
Investor Relations:

Katie Battaglia
Tel: (416) 359-8544
Email: [email protected]



Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of Canadian provincial securities laws and “forward-looking statements” within the meaning of the U.S. Securities Act of 1933, the U.S. Securities Exchange Act of 1934, “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and in any applicable Canadian securities regulations (collectively, “forward-looking statements”). Forward-looking statements include statements that are predictive in nature, depend upon or refer to future results, events or conditions, and include, but are not limited to, statements which reflect management’s current estimates, beliefs and assumptions and which in turn are based on our experience and perception of historical trends, current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. The estimates, beliefs and assumptions of Brookfield are inherently subject to significant business, economic, competitive and other uncertainties and contingencies regarding future events and as such, are subject to change. Forward-looking statements are typically identified by words such as “expect”, “anticipate”, “believe”, “foresee”, “could”, “estimate”, “goal”, “intend”, “plan”, “seek”, “strive”, “will”, “may” and “should” and similar expressions. In particular, the forward-looking statements contained in this news release include statements referring to the offering, the expected use of proceeds from the offering and the expected closing date of the offering.

Although Brookfield believes that such forward-looking statements are based upon reasonable estimates, beliefs and assumptions, c
ertain factors, risks and uncertainties, which are described from time to time in our documents filed with the securities regulators in Canada and the United States, not presently known to Brookfield, or that Brookfield currently believes are not material, could cause actual results to differ materially from those contemplated or implied by forward-looking statements.

Readers are urged to consider these risks, as well as other uncertainties, factors and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements, which are based only on information available to us as of the date of this news release. Except as required by law, Brookfield undertakes no obligation to publicly update or revise any forward-looking statements, whether written or oral, that may be as a result of new information, future events or otherwise.